Update on diagnosis, treatment, and prevention of genital human papillomavirus manifestations

Stanley, 2006, Prospects for eradicationg ano-genital neoplasia, Med Virol, 16, 139, 10.1002/rmv.498 Kodner, 2004, Management of genital warts, Am Fam Physician, 70, 2335 O'Mahony, 2005, Genital warts current and future management options, Am J Clin Dermatol, 6, 239 Gunter, 2003, Genital and perinatal warts: new treatment opportunities for human papillomavirus infection, Am J Obstet Gynecol, 289, S3, 10.1067/S0002-9378(03)00789-0 Wiley, 2002, External genital warts: diagnosis, treatment, and prevention, Clin Infect Dis, 35, S210, 10.1086/342109 Mayeaux, 2008, Modern management of external genital warts, J Low Gen Tract Dis, 12, 185, 10.1097/LGT.0b013e31815dd4b4 Ault, 2004, Human papillomavirus infections: diagnosis, treatment, and hope for a vaccine, Obstet Gynecol Clin North Am, 30, 809, 10.1016/S0889-8545(03)00102-5 Garland, 2009, Human papillomavirus infections and vulvar disease development, Cancer Epidemiol Biomarkers Prev, 18, 1777, 10.1158/1055-9965.EPI-09-0067 Insinga, 2008, A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States, Cancer Epidemiol Biomarkers Prev, 17, 1611, 10.1158/1055-9965.EPI-07-2922 Bruchim, 2007, HPV-related vulvar intraepithelial neoplasia: outcome of different management modalities, Int J Gyn Obstet, 99, 23, 10.1016/j.ijgo.2007.03.023 Wright, 2007, 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ, Am J Obstet Gynecol, 197, 340, 10.1016/j.ajog.2007.07.050 Wright, 2007, 2006 consensus guidelines for the management of women with abnormal cervical screening tests, Am J Obstet Gynecol, 197, 346, 10.1016/j.ajog.2007.07.047 Gravitt, 2005, Diagnosis and management of oncogenic cervical human papillomavirus infection, Infect Dis Clin North Am, 19, 439, 10.1016/j.idc.2005.03.008 Von Krogh, 1978, Topical treatment of penile condylomata acuminata with podophyllin, podophyllotoxin and colchicine, Acta Derm Venereol, 58, 163 Von Krogh, 1992, Self-treatment using a 0.5% podophyllotoxin cream of external genital condylomata acuminata in women, Sexually Transmitted Diseases, 19, 170, 10.1097/00007435-199205000-00012 Yan, 2006, Meta-analysis of 5% imiquimod and 0.5% podophyllotoxin in the treatment of condylomata acuminate, Dermatology, 213, 218, 10.1159/000095039 Beutner, 1998, Treatment of genital warts with an immune-response modifier (imiquimod), J Am Acad Dermatol, 38, 230, 10.1016/S0190-9622(98)70243-9 Edwards, 1998, Self-administered topical 5% imiquimod cream for external anogenital warts, Arch Dermatol, 134, 25, 10.1001/archderm.134.1.25 Maitland, 2000, An audit of patients who have received imiquimod cream 5% for the treatment of anogenital warts, Int J STD AIDS, 11, 268, 10.1258/0956462001915697 Tatti, 2010, Polyphenon E®: a new treatment for external anogenital warts, Br J Dermatol, 162, 176, 10.1111/j.1365-2133.2009.09375.x Stockfleth, 2008, Topical Polyphenon® E in the treatment of external genital and perianal warts: a randomized controlled trial, Br J Dermatol, 158, 1329, 10.1111/j.1365-2133.2008.08520.x Langley, 2010, A cost-effectiveness analysis of sinecatechins in the treatment of external genital warts, J Med Econ, 13, 1, 10.3111/13696990903451461 Taner, 2007, Therapeutic value of trichloracetic acid in the treatment of isolated genital warts on the external female genitalia, J Reprod Med, 52, 521 Del Priore, 2010, Oral diindoylmethane (DIM): pilot evaluation of a non surgical treatment for cervical dysplasia, Gynecol Oncol, 116, 464, 10.1016/j.ygyno.2009.10.060 Winer, 2006, Condom use and the risk of genital human papillomavirus infection in young women, N Engl J Med, 354, 2645, 10.1056/NEJMoa053284 Kawana, 2009, Human papillomavirus vaccines: current issues and future, Indian J Med Res, 130, 341 Paavonen, 2009, Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomized study in young women, Lancet, 374, 301, 10.1016/S0140-6736(09)61248-4 Garland, 2007, Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases, N Engl J Med, 356, 1928, 10.1056/NEJMoa061760 2009, Science eyes HPV vaccine use in men—will shot be approved for U.S. males?, Contraceptive Technology Update, 30, 85 Giuliano, 2011, Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males, N Engl J Med, 364, 401, 10.1056/NEJMoa0909537 Harper, 2009, Currently approved prophylactic HPV vaccines, Exp Rev Vaccines, 8, 1663, 10.1586/erv.09.123